Opus Genetics, Inc. Common Stock Share Price
NYSE: IRD
Live Opus Genetics, Inc. Common Stock Share Price Chart
O H L
Opus Genetics, Inc. Common Stock Performance Overview
Days Range
▼
$5.13Low
$5.25High
Markets Today
| Previous Close | $5.28 |
|---|---|
| Open | $5.24 |
| Volume | 168,010 |
| Day's Range | $5.13 - $5.25 |
| 52W Range | NA |
| Market Cap | $450.09 M |
Historical Performance
| 1M Returns | +43.09 |
|---|---|
| 3M Returns | +29.73 |
| 6M Returns | +13.30 |
| 1Y Returns | +254.36 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Opus Genetics, Inc. Common Stock Fundamentals
| Market Cap | $450.09 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $14.20 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-38.55 M |
| Profit Margin | -349.33 |
| Market Cap | $450.09 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $14.20 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-38.55 M |
| Profit Margin | -349.33 |
Opus Genetics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $4.37 M | $2.88 M | $3.08 M | $3.87 M | $2.16 M | $755.00 K |
| Gross Profit + | $4.37 M | $2.88 M | $3.08 M | $3.87 M | $2.16 M | $755.00 K |
| Operating Income | -$9.93 M | -$8.91 M | -$8.31 M | -$11.45 M | -$14.36 M | -$16.48 M |
| EBITDA | -$9.92 M | -$8.89 M | -$8.30 M | -$11.44 M | -$14.35 M | -$16.47 M |
| Interest Expense | -$1.37 M | $35.00 K | -$68.00 K | $1.28 M | -$651.00 K | -$531.00 K |
| Depreciation | $13.00 K | $14.00 K | $13.00 K | $13.00 K | $13.00 K | $14.00 K |
| Income Before Tax | -$8.19 M | -$7.42 M | -$17.45 M | -$16.52 M | -$65.53 M | -$8.10 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$8.19 M | -$7.42 M | -$17.45 M | -$16.52 M | -$65.53 M | -$8.10 M |
| Net Profit Margin | -187.51% | -257.46% | -566.87% | -427.5% | -3038.25% | -1072.58% |
Opus Genetics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $5.00 K | $6.00 K | $6.00 K | $7.00 K | $7.00 K | $8.00 K |
| Reserve & Surplus | -$147.19 M | -$154.61 M | -$172.07 M | -$188.59 M | -$254.12 M | -$262.22 M |
| Non-Current Liabilities | $0 | $1.00 M | $1.07 M | $27.11 M | $78.55 M | $98.35 M |
| Current Liabilities | $24.25 M | $20.19 M | $29.09 M | $7.78 M | $9.34 M | $7.61 M |
| Total Liabilities | $24.25 M | $21.19 M | $30.16 M | $34.90 M | $87.89 M | $105.95 M |
| Fixed Assets | $239.00 K | $226.00 K | $212.00 K | $199.00 K | $186.00 K | $172.00 K |
| Current Assets | $47.93 M | $38.44 M | $35.91 M | $50.04 M | $66.60 M | $92.70 M |
| Total Assets | $48.17 M | $38.66 M | $36.12 M | $50.24 M | $66.79 M | $92.97 M |
Opus Genetics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$8.19 M | -$7.42 M | -$17.45 M | -$16.52 M | -$65.53 M | -$8.10 M |
| Operating Cash Flow | -$8.99 M | -$10.27 M | -$6.16 M | -$9.83 M | -$12.73 M | -$11.95 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $20.46 M | $906.00 K | $4.54 M | $24.11 M | $27.59 M | $40.90 M |
| Change in Cash | $11.47 M | -$9.36 M | -$1.61 M | $14.28 M | $14.87 M | $28.95 M |
Opus Genetics, Inc. Common Stock Return Calculator
The Opus Genetics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Opus Genetics, Inc. Common Stock
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.
Popular Stocks
FAQs
What is the share price of Opus Genetics, Inc. Common Stock today?
Opus Genetics, Inc. Common Stock (IRD) share price as of September 18, 2026 is $5.09. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Opus Genetics, Inc. Common Stock?
Yes, Indian Investors can invest in the Opus Genetics, Inc. Common Stock (IRD) Share by opening an international trading account with Angel One.
How can I purchase Opus Genetics, Inc. Common Stock shares in India?
Purchasing Opus Genetics, Inc. Common Stock (IRD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Opus Genetics, Inc. Common Stock (IRD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Opus Genetics, Inc. Common Stock?
Yes, you can purchase fractional shares of Opus Genetics, Inc. Common Stock (IRD) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Opus Genetics, Inc. Common Stock?
The market capitalization of Opus Genetics, Inc. Common Stock on September 18, 2026, is $450.09 M.
In which sector Opus Genetics, Inc. Common Stock belongs?
Opus Genetics, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Opus Genetics, Inc. Common Stock stocks?
In order to invest in Opus Genetics, Inc. Common Stock (IRD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
